-
UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcement
Read more: UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcementThe UPC Hague LD upheld 12 claims of GSK’s liposome patent, finding that Pfizer and BioNTech’s Comirnaty vaccine infringes six of them. It revoked one medical-use claim for insufficiency and granted a pan-European injunction, subject to deferred enforcement.
-
Pictiva sues BOE in Texas after Samsung settlement that followed $191M jury verdict
Read more: Pictiva sues BOE in Texas after Samsung settlement that followed $191M jury verdictPictiva Displays International, an affiliate of Key Patent Innovations, has accused the Chinese company of infringing five patents relating to OLED display technology.
-
UPC infringement filings reach 2026 high of 40 in October, German divisions’ monthly share falls to 67.5%
Read more: UPC infringement filings reach 2026 high of 40 in October, German divisions’ monthly share falls to 67.5%The UPC also logged 11 new stand-alone revocation actions, five provisional measures applications, and 69 first-instance cases overall in October 2026, while The Hague had its busiest month of the year.
-
UPC Milan accepts parent-company guarantee in Nixu v. Amazon security-for-costs dispute
Read more: UPC Milan accepts parent-company guarantee in Nixu v. Amazon security-for-costs disputeThe UPC’s Milan Local Division has rejected Amazon’s €600,000 security-for-costs request against Nixu, finding that a parent-company guarantee provides sufficient protection despite potential enforcement complications under Texas law.
-
Netlist looks to build on Micron momentum with ITC & California campaign targeting Kingston
Read more: Netlist looks to build on Micron momentum with ITC & California campaign targeting KingstonThis latest ITC complaint from Netlist also names Lenovo and several distributors of Kingston products as respondents.
-
Samsung, ASUS seek to dismiss NPE display patent suit, Samsung challenging six of those patents at USPTO
Read more: Samsung, ASUS seek to dismiss NPE display patent suit, Samsung challenging six of those patents at USPTOSamsung Display has asked the USPTO to reexamine NeoLayer’s ‘583 patent, reportedly its sixth challenge, while ASUS and Samsung Electronics have filed a motion to dismiss a parallel Texas case for lack of standing.
-
South Korean patent fights: court denies LG Chem injunction against JS Energy, mediation takes center stage in Hanmi and Hanwha Semitech case
Read more: South Korean patent fights: court denies LG Chem injunction against JS Energy, mediation takes center stage in Hanmi and Hanwha Semitech caseA Seoul court has refused LG Chem’s request to halt rival JS Energy’s cathode production, while Hanmi and Hanwha Semitech postponed a hearing for mediation.
-
Moderna and GlaxoSmithKline settle mRNA vaccine dispute with cross-license; “not obligated to make payments”
Read more: Moderna and GlaxoSmithKline settle mRNA vaccine dispute with cross-license; “not obligated to make payments”The agreement settles pending litigation in the United States and Europe.
Follow Us
Latest Articles
- UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcement
- Pictiva sues BOE in Texas after Samsung settlement that followed $191M jury verdict
- UPC infringement filings reach 2026 high of 40 in October, German divisions’ monthly share falls to 67.5%
- UPC Milan accepts parent-company guarantee in Nixu v. Amazon security-for-costs dispute
- Netlist looks to build on Micron momentum with ITC & California campaign targeting Kingston